← Browse by Condition
Medical Condition

primary sjogren s disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07404865 Phase 3
Recruiting

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Enrollment
250 pts
Location
United States
Sponsor
Vor Biopharma
View Trial →